Bicocca Open Archive

Logo unimib boa
BIAGI, ETTORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.738
EU - Europa 3.123
AS - Asia 972
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 7
AF - Africa 5
Totale 13.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.589
SE - Svezia 675
CN - Cina 556
DE - Germania 524
UA - Ucraina 464
IE - Irlanda 463
IT - Italia 376
GB - Regno Unito 195
HK - Hong Kong 186
CA - Canada 142
FI - Finlandia 112
VN - Vietnam 89
FR - Francia 58
TR - Turchia 51
BE - Belgio 44
IN - India 43
RU - Federazione Russa 43
AT - Austria 42
DK - Danimarca 37
NL - Olanda 34
BG - Bulgaria 20
JP - Giappone 13
SG - Singapore 12
BR - Brasile 10
EU - Europa 10
IR - Iran 10
RO - Romania 9
ES - Italia 7
CH - Svizzera 6
MX - Messico 6
AU - Australia 5
ID - Indonesia 4
KR - Corea 4
MU - Mauritius 4
CL - Cile 3
PL - Polonia 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IL - Israele 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
A1 - Anonimo 1
AL - Albania 1
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
Totale 13.876
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Woodbridge 1.238
Fairfield 876
Houston 810
Chandler 724
Wilmington 691
Ashburn 527
Jacksonville 516
Dublin 454
Seattle 373
Cambridge 335
Frankfurt am Main 325
Dearborn 316
Princeton 194
Hong Kong 183
New York 173
Nanjing 133
Milan 108
Lawrence 85
Lachine 83
Beijing 69
Altamura 68
Shanghai 66
Dong Ket 60
San Diego 47
Brussels 42
Vienna 41
Nanchang 38
Boardman 35
Andover 33
Lissone 33
Tianjin 31
Fremont 30
Toronto 30
Hebei 27
Helsinki 27
Mountain View 26
Shenyang 26
Huizen 23
Hangzhou 20
Plovdiv 20
Guangzhou 18
Jinan 18
Changsha 17
Ningbo 16
Jiaxing 15
Los Angeles 15
Falls Church 14
Kocaeli 14
Nürnberg 14
Ottawa 14
Auburn Hills 13
London 13
University Park 13
Edmonton 12
Norwalk 12
Zhengzhou 12
Philadelphia 11
Chicago 10
Rome 10
Taizhou 9
Contursi 8
Detroit 8
Kunming 8
Washington 8
Hefei 7
Redmond 7
Brooklyn 6
São Paulo 6
Brescia 5
Madrid 5
San Mateo 5
Tappahannock 5
Cuauhtémoc 4
Florence 4
Hanoi 4
Missaglia 4
Napoli 4
Bergamo 3
Bonndorf 3
Cardano al Campo 3
Central 3
Cerreto Guidi 3
Changchun 3
Chengdu 3
Clearwater 3
Como 3
Daejeon 3
Desio 3
Genova 3
Grafing 3
Hounslow 3
Jakarta 3
Kiev 3
Kyiv 3
Lanzhou 3
Leawood 3
Limbiate 3
Melbourne 3
Muggiò 3
Totale 10.975
Salva come PNG Salva come JPEG
Nome #
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 308
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 281
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 276
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 264
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 244
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 234
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 233
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 226
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 223
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 223
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 222
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 219
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 212
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 200
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 198
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 196
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 192
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 191
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 190
Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells 189
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 186
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 182
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 179
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 179
Chimeric T-cell receptors: New challenges for targeted immunotherapy in hematologic malignancies 177
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 177
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 175
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes 174
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 173
Upregulation of Adhesion Molecules on Leukemia Targets Improves the Efficacy of Cytotoxic T Cells Transduced With Chimeric Anti-CD19 Receptor 169
Antigen-induced regulatory T cells 165
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 165
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 164
Chimeric Antigen Receptors against CD33/CD123 antigens efficiently target primary Acute Myeloid Leukemia cells in vivo 164
Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine 159
Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cells 157
GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy 156
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives 155
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells 155
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 155
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia 155
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor 153
Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library 152
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 149
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis 149
Donor-derived CD19-targeted T cells in allogeneic transplants 149
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 147
Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells 147
CD40 activation of BCP-ALL cells generates 11L-10-producing, 11L-12-defective APCs that induce allogeneic T-cell anergy 146
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes 146
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia 146
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device 144
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia 142
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 140
Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukemia 139
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 138
Role of early diagnosis for a noninvasive treatment of pulmonary thromboembolism in leukemic children 138
A life-threatening paediatric case of acute autoimmune haemolytic anaemia (AIHA) successfully cured by plasma-exchange and combined immunosuppressive treatment 138
Cytokine Induced Killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors 136
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. 135
Intrathecal chemotherapy with antineoplastic agents in children 133
PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients. 131
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells 129
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis 128
Estudio experimental sobre la utilización de células madre humanas en la terapia de los defectos periodontales: resultados preliminares 126
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 126
Development of an alveolar bone regeneration protocol with mesenchyl stem cells for the therapy of severe bone resorption in periodontal disease 125
Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: A case report 122
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 121
Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside 120
Cell-based strategies to manage leukemia relapse: Efficacy and feasibility of immunotherapy approaches 120
From Bone Marrow Transplantation to Cellular Therapies: Possible therapeutic strategies in managing autoimmune disorders 120
Effectiveness of extracorporeal photochemotherapy in treating long-term refractory chronic graft-versus-host disease 118
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 118
T lymphocytes redirected against the κ light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells 117
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future 107
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia 107
The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs 105
In Vitro Comparison of Three Different Chimeric Receptor-modified Effector T-cell Populations for Leukemia Cell Therapy 105
Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain 105
In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid Leukemia 101
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression. Mol Cancer 98
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 96
Phase I Trial of Vaccination With Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 and Lymphotactin 94
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT. 93
Long term efficacy of human bone marrow mesenchymal stem cells in traumatized mice brain is not affected by immunosuppressive treatment 92
A Phase 1/2 Study of Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 in Patients With High-risk Neuroblastoma 91
Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells 90
null 78
Mesenchymal stem/stromal cells: a new "cells as drugs" paradigm. Efficacy and critical aspects in cell therapy 74
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT. 66
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT. 60
New findings about the Interplay among Clarithromycin, Immune and Central Nervous Systems 60
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo 32
Totale 14.284
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019754 0 0 0 0 0 0 0 0 0 0 348 406
2019/20203.022 361 210 234 271 293 376 422 196 281 131 182 65
2020/20212.003 120 164 292 204 139 138 166 124 153 223 85 195
2021/20221.376 51 135 208 106 71 68 58 66 138 134 98 243
2022/20232.370 271 739 198 224 136 355 24 151 171 6 69 26
2023/20241.198 46 39 61 56 202 348 264 62 112 8 0 0
Totale 14.284